Sign in to continue:

Tuesday, March 24th, 2026

Day: March 19, 2026

XOMA Royalty Corp 2025 Annual Report: Financials, Nasdaq Listings, and Key Agreements (10-K Filing)

XOMA Royalty Corporation 2025 10-K: Key Investor Insights ...

Moleculin Biotech 2025 Annual Report: Annamycin Clinical Trials & Pipeline Update

Moleculin Biotech, Inc. (NASDAQ: MBRX) 2025 Annual Report: K...